Anbio Biotechnology (NNNN) Equity Average (2024)
Anbio Biotechnology's Equity Average history spans 1 years, with the latest figure at $16.0 million for Q4 2024.
- Quarterly Equity Average changed N/A to $16.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $16.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at $23.7 million for FY2025, 47.91% up from the prior year.
- Equity Average came in at $16.0 million for Q4 2024.
- In the past five years, Equity Average ranged from a high of $16.0 million in Q4 2024 to a low of $16.0 million in Q4 2024.